title: NIMRAD - a phase III trial to investigate the use of nimorazole hypoxia modification with intensity-modulated radiotherapy in head and neck cancer.
authors.affiliation: Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK; Institute of Cancer Sciences, The University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK.
authors.forename: D
authors.initials: D
authors.lastname: Thomson
authors.affiliation: NCRI Radiotherapy Trials Quality Assurance Groups (RTTQA), Mount Vernon Hospital, Northwood, Middlesex, UK.
authors.forename: H
authors.initials: H
authors.lastname: Yang
authors.affiliation: NCRI Radiotherapy Trials Quality Assurance Groups (RTTQA), The Royal Marsden Foundation Trust, London, UK.
authors.forename: H
authors.initials: H
authors.lastname: Baines
authors.affiliation: NCRI Radiotherapy Trials Quality Assurance Groups (RTTQA), Mount Vernon Hospital, Northwood, Middlesex, UK.
authors.forename: E
authors.initials: E
authors.lastname: Miles
authors.affiliation: Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK.
authors.forename: S
authors.initials: S
authors.lastname: Bolton
authors.affiliation: Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK; Institute of Cancer Sciences, The University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK.
authors.forename: C
authors.initials: C
authors.lastname: West
authors.affiliation: Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: Nick.Slevin@christie.nhs.uk.
authors.forename: N
authors.initials: N
authors.lastname: Slevin
mesh_terms: D006801:Humans; D000994:Antitrichomonal Agents / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy; D015687:Cell Hypoxia; D003131:Combined Modality Therapy; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D009554:Nimorazole / Q000008:administration & dosage; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage; D050397:Radiotherapy, Intensity-Modulated / Q000379:methods; D012107:Research Design; D000077195:Squamous Cell Carcinoma of Head and Neck; D017326:Clinical Trials, Phase III as Topic; D016032:Randomized Controlled Trials as Topic; D015337:Multicenter Studies as Topic
chemical_list: D000994:Antitrichomonal Agents; D009554:Nimorazole; D011838:Radiation-Sensitizing Agents